Skip to main content

AMGEN INC

For the period ended Sep 30, 2026. Filed Nov 4, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 4, 2026

AMGN$465.230.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

Three months endedSeptember 30,Nine months endedSeptember 30,
2026202520262025
Revenues:
Product sales$9,883$9,137$27,638$25,781
Other revenues4824201,3991,104
Total revenues10,3659,55729,03726,885
Operating expenses:
Cost of sales2,7883,0828,3439,061
Research and development2,1111,9005,6985,130
Selling, general and administrative1,6801,7205,0275,098
Other76329791,236
Total operating expenses6,6557,03119,14720,525
Operating income3,7102,5269,8906,360
Other income (expense):
Interest expense, net(653)(685)(1,983)(2,102)
Other income, net1,6292,0801,6313,204
Income before income taxes4,6863,9219,5387,462
Provision for income taxes8227051,4801,084
Net income$3,864$3,216$8,058$6,378
Earnings per share:
Basic$7.14$5.98$14.92$11.86
Diluted$7.08$5.93$14.79$11.77
Weighted-average shares used in calculation of earnings per share:
Basic541538540538
Diluted546542545542
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.